Vanrafia Tablet, Film Coated
Product Images NDC 0078-1420

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vanrafia (NDC 0078-1420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Atrasentan Structural Formula (Vanrafia 01)

Atrasentan Structural Formula (Vanrafia 01)
Chemical structure of atrasentan hydrochloride, the active ingredient in VANRAFIA, shown as a complex molecular diagram with labeled functional groups including HCl and hydroxyl moieties.*
FDA Label Image

Figure 1: Geometric Mean Percent Change From Baseline In Upcr By Visit In Align (Vanrafia 02)

Figure 1: Geometric Mean Percent Change From Baseline In Upcr By Visit In Align (Vanrafia 02)
A line graph comparing adjusted geometric mean percent changes over time between VANRAFIA and placebo groups across several weeks (0, 6, 12, 24, 36). The y-axis shows adjusted geometric mean percent change with 95% confidence intervals, and the x-axis represents visit weeks. VANRAFIA's line shows a downward trend with decreasing percent change, while placebo remains near zero change.*
FDA Label Image

Principal Display Panel Ndc 0078-1420-15 Rx Only Vanrafia™ (atrasentan) Tablets 0.75 mg Dispense With Accompanying Medication Guide. Swallow Tablets Whole. Do Not Cut, Crush, Or Chew. 30 Tablets Novartis (Vanrafia 03)

Principal Display Panel Ndc 0078-1420-15 Rx Only Vanrafia™ (atrasentan) Tablets 0.75 mg Dispense With Accompanying Medication Guide. Swallow Tablets Whole. Do Not Cut, Crush, Or Chew. 30 Tablets Novartis (Vanrafia 03)
Label for VANRAFIA 0.75 mg atrasentan tablets, film-coated, oral use. The label includes dosage instructions, storage conditions, and warnings to swallow whole and not crush or chew. The product contains 30 tablets and is labeled for prescription use only. Manufactured by AbbVie Ireland NL B.V. and distributed by Novartis Pharmaceuticals Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.